0000059478-15-000082.txt : 20150209 0000059478-15-000082.hdr.sgml : 20150209 20150209131546 ACCESSION NUMBER: 0000059478-15-000082 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150209 DATE AS OF CHANGE: 20150209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Zosano Pharma Corp CENTRAL INDEX KEY: 0001587221 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 454488360 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88596 FILM NUMBER: 15587674 BUSINESS ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 510-745-1200 MAIL ADDRESS: STREET 1: 34790 ARDENTECH COURT CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: ZP Holdings Inc DATE OF NAME CHANGE: 20130919 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: LILLY ELI & CO CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1112 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 SC 13G 1 zosanopharma-schedule13g_2.htm SC 13G Zosano Pharma - Schedule 13G_2015







UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934


Zosano Pharma Corporation
(Name of lssuer)

Common Stock; $0.0001 par value
(Title of Class of Securities)

98979H103
(CUSIP Number)
January 30, 2015
(Date of Event Which Requires Filing of this Statement)



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ]    Rule 13d-l (b)
[x]     Rule 13d-l (c)
[ ]     Rule 13d-l (d)


*The remainder of this cover page shall be filled out for a reporting person's initial filing of this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act.







1.     Name of Reporting Person
I.R.S. Identification No. of Above Person (Entities Only)

Eli Lilly and Company
    
2.         Check the Appropriate Box if a Member of a Group
(a)__(b)__
3.     SEC Use Only
4.     Citizenship or Place of Organization

Indiana

Number of shares beneficially owned by each reporting person with:

5.     Sole Voting Power: 1,363,636

6.    Shared Voting Power: 0

7.     Sole Dispositive Power: 1,363,636

8.     Shared Dispositive Power:     0
9.     Aggregate Amount Beneficially Owned by Each Reporting Person

1,363,636
10.     Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares
[ ]
11.     Percent of Class Represented by Amount in Row (9)

11.5%

12.     Type of Reporting Person
CO



2



Item l(a)     Name of Issuer

Zosano Pharma Corporation

Item l(b)     Address of Issuer's Principal Executive Offices

34790 Ardentech Court
Fremont, California 94555

Item 2(a)     Name of Person Filing

This Statement is filed on behalf of     Eli Lilly and Company, an Indiana corporation.
Item 2(b)     Address of Principal Business Office, or if none, Residence

Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285.
        
        
Item 2(c)     Citizenship

Eli Lilly and Company is an Indiana corporation.


Item 2(d)     Title of Class of Securities

Common Stock, par value $0.0001 per share

Item 2(e)     CUSIP Number

98979H103

Item 3.     Filing pursuant to Rules 13d-l(b) or 13d-2(b) or (c)

Not Applicable


Item 4.     Ownership

(a)     Amount Beneficially Owned:

1,363,636

(b)     Percent of Class:

11.5%

(c)     Number of shares as to which the person has:

Sole power to vote or to direct the vote:             1,363,636
    
Shared power to vote or to direct the vote:             0

Sole power to dispose or to direct the disposition of:         1,363,636

Shared power to dispose or to direct the disposition of:     0


3


Item 5.         Ownership of Five Percent or Less of a Class

Not Applicable

 
Item 6.         Ownership of More than Five Percent on Behalf of Another Person

Not Applicable

Item 7.         Identification and Classification of the Subsidiary Which Acquired the Security
Being Reported on By the Parent Holding Company

Not Applicable

Item 8.         Identification and Classification of Members of the Group

Not Applicable

Item 9.         Notice of Dissolution of Group

Not Applicable

Item 10.     Certification

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.




SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date:     February 9, 2015

ELI LILLY AND COMPANY
By:     /s/ James B. Lootens
Name: James B. Lootens
Title: Secretary



This filing is made voluntarily and should not be construed as an admission that the reporting persons are subject to reporting requirements under Section 13 of the Securities Exchange Act of 1934.


4